Table 4. Utility parameters.
| Health states | Mean | SE | Distribution* | Reference |
|---|---|---|---|---|
| Chronic HCV infection | 0.73 | 0.0011 | Beta | [40] |
| Compensated cirrhosis | 0.70 | 0.0020 | Beta | [40] |
| Decompensated cirrhosis | 0.58 | 0.0020 | Beta | [40] |
| Hepatocellular carcinoma | 0.58 | 0.0023 | Beta | [40] |
| Anemia in chronic HCV infection† | 0.61 | 0.0018 | Beta | [40, 41] |
*Probability distribution for employing uncertainty analysis in economic evaluation
†Analysis of secondary data collected by the authors. Subtraction of disutility due to anemia from utility value of chronic HCV infection